Праці Наукового товариства імені Шевченка. Медичні науки
Icosapent ethyl and atherosclerotic cardiovascular disease in type 2 diabetes (narrative review)
By Victoria Serhiyenko, Liudmyla Serhiyenko, Andriy Cherkas and 1 others.
Abstract
This narrative review was aimed to analyze the current views on the biochemical and molecular mechanisms of ω-3 polyunsaturated fatty acids (ω-3 PUFAs), in particular icosapent ethyl (IPE), in atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes mellitus (T2D). The results of experimental, cohort, prospective, randomized clinical trials confirm the prospects of using IPE to prevent and treat ASCVD in T2D. Search Techniques. Databases from Scopus, Science Direct (from Elsevier), EBSCO, PubMed, and Medline were all searched. To find trials that were missed by the web search, a manual search of the publishing bibliographies was conducted.
Keywords
- ω-3 polyunsaturated fatty acids, icosapent ethyl, atherosclerotic cardiovascular disease, type 2 diabetes mellitus.
Source
Published in Праці Наукового товариства імені Шевченка. Медичні науки. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
